Background
==========

In a series of electromyographic (EMG) fatigue studies, Moritani et al. \[[@B1],[@B2]\] demonstrated an increase in EMG activity during incremental cycling exercise. It has been suggested that the rise in electrical activity is a result of progressive recruitment of additional motor units (MU) and/or an increase in the firing frequency of MUs that have already been recruited \[[@B3]\]. An exercise-induced decrease in intramuscular pH, due to increases in hydrogen ions \[H^+^\], may interfere with the excitation-contraction coupling process of skeletal muscle, which, in turn, may lead a to decrease in power output and fatigue \[[@B4]\]. Thus, if power output is to be maintained, either additional MUs must be recruited or the firing rates of the already active MUs must increase. In either case, a rise in EMG amplitude with power output takes place due to increases in muscle activation.

The physiological mechanism responsible for the increase in EMG amplitude over time during a fatiguing task is unknown. Three potential mechanisms, however, include the accumulation of metabolic by-products (lactate, hydrogen ions (H^+^), inorganic phosphate (Pi), and ammonia), the depletion of stored energy substrates (ATP, phosphocreatine (PCr), and glycogen) and/or impaired muscle cation (potassium (K^+^), sodium (Na^+^) and calcium (Ca^2+^) regulation \[[@B5]-[@B7]\]. Several investigations have used surface electromyography to characterize the fatigue-induced increase in EMG amplitude, as well as to identify the power output associated with the onset of neuromuscular fatigue during cycle ergometry \[[@B2],[@B8]-[@B11]\]. Furthermore, surface EMG has been shown to be an acceptable method for non-invasive assessment of muscle fatigue of active muscles \[[@B12],[@B13]\].

Matsumoto et al. \[[@B9]\] and Moritani et al. \[[@B2]\] have proposed an incremental cycle ergometer test utilizing fatigue curves to identify the maximal power output at which an individual can maintain without evidence of fatigue, called the electromyographic fatigue threshold (EMG~FT~). The EMG~FT~test is an adaptation to deVries original monopoloar physical working capacity at the fatigue threshold (PWC~FT~) test \[[@B14]\], using a bipolar supramaximal protocol, which involves determining the rate of rise in electrical activity from the vastus lateralis during four, 60 second work bouts on a cycle ergometer, with varying power outputs. The four power outputs are then plotted as a function of four EMG slope coefficients, with the y-intercept defined as the electromyographic fatigue threshold (EMG~FT~).

Matsumoto et al\[[@B9]\] described the EMG~FT~as the highest intensity sustainable on a cycle ergometer without signs of neuromuscular fatigue. In addition, Moritani et al. \[[@B2]\] suggested a strong physiological link between myoelectrical changes at fatigue and anaerobic threshold. Furthermore, the EMG~FT~method has been reported as a valid and reliable technique for examining the transition from aerobic to anaerobic metabolism during exercise \[[@B8],[@B12],[@B13]\].

Harris et al. \[[@B15]\] were the first to demonstrate a 20% increase in muscle creatine (Cr) after ingestion of 20 g/day of Cr (four doses of 5 g) (Cr) for 5 days, with a 30% increase as phosphocreatine (PCr). The effect Cr supplementation on anaerobic activities, utilizing anaerobic energy reserves (adenosine triphosphate (ATP) PCr) has received a large amount of attention. It has been suggested that skeletal muscle PCr may serve as a temporal energy buffer as well as a modulator of glycolysis, and that, if increased via Cr supplementation, may influence neuromuscular fatigue \[[@B11],[@B16]\]. Although Cr has been reported to be most effective in anaerobic activities, some evidence suggests that Cr may serve as an effective temporal energy buffer \[[@B17],[@B18]\] and may enhance aerobic activities\[[@B11],[@B19],[@B20]\].

Although women have been underrepresented in the Cr literature, recent studies suggest that there are no gender differences in the amount of increase of total creatine (TCr) following loading \[[@B15],[@B21]\] nor are there differences in high intensity exercise performance \[[@B22]\]. In addition, Stout et al. \[[@B11]\] demonstrated improvements in neuromuscular fatigue after 5 days of Cr loading (4 × 5 g·d^-1^) in trained female athletes, with a significant (p \< 0.05) increase in PWC~FT~. To date, however, no studies have examined the effects of Cr loading on EMG~FT~in women. Therefore, the purpose of this study was to examine the effects of 5 days of Cr loading on EMG~FT~in college-aged women.

Methods
=======

Participants
------------

Fifteen healthy, recreationally trained (1--5 hours/week) college-aged women volunteered to participate in this investigation (Table [1](#T1){ref-type="table"}). All procedures were approved by the University of Oklahoma Institutional Review Board for Human subjects and written informed consent was obtained from each participant prior to any testing.

###### 

Age, height, and body weight of the participants at baseline.

                     Age (years)   Height (cm)   Weight (kg)
  ------------------ ------------- ------------- -------------
  Creatine (n = 7)   22.4 ± 0.5    168.8 ± 1.3   66.0 ± 3.6
  Placebo (n = 8)    22.3 ± 0.7    170.3 ± 2.9   64.7 ± 2.9

Values expressed as mean ± SE

Supplementation
---------------

This was a randomized, double-blind, placebo-controlled design. Participants were randomly assigned to either the placebo (PL -- 10 g of flavored dextrose powder per packet; n = 9) or creatine (Cr -- 5 g di-creatine citrate plus 10 g of flavored dextrose powder per packet; n = 7) (Creatine Edge, FSI Nutrition Inc. Omaha, NE) groups. Both treatments were effervescent powders, pre-packaged to be identical in taste and appearance, and were dissolved in 8--12 oz of water. Each group ingested one packet 4 times per day at regular intervals (every 3--4 hours) for 5 days (total of 20 g/day). Throughout the duration of the study, participants were asked to refrain from physical activity and caffeine consumption, for at least 24 hours prior to testing.

Electromyography
----------------

Pre-gelled bipolar (2.54 cm center-to-center) surface electrodes (Ag-Ag Cl, Quinton Quick Prep, Quinton Instruments Co., Bothell, WA) were placed on the right thigh over the lateral portion of the vastus lateralis muscle, midway between the greater trochanter and the lateral condyle of the femur \[[@B1],[@B2],[@B9]-[@B11],[@B23]\]. A single reference electrode was placed over the spinous process of the 7^th^cervical vertibrae. Interelectode impedance was kept below 2,000 Ω by careful abrasion of the skin. The raw EMG signals were pre-amplified (gain × 1,000) using a differential amplifier (EMG 100C, Biopac Systems, Inc., Santa Barbara, CA), sampled at 1,000 Hz and bandpass filtered from 10--500 Hz (zero-lag 8^th^order Butterworth filter). All EMG amplitude values were stored on a personal computer (Dell Inspiron 8200, Dell, Inc., Round Rock, TX) and analyzed off-line using custom written software (LabVIEW v 7.1, National Instruments, Austin, TX).

Determination of EMG~FT~
------------------------

The EMG~FT~was determined using the EMG amplitude values from the vastus lateralis muscle while cycling on an electronically braked cycle ergometer (Quinton Corival 400), with the seat height adjusted at near full extension of the legs while pedaling. After a 5 minute warm-up (50 W), the participants performed four, 60 second incrementally ascending workloads (100 W--350 W) at a set cadence of 70 rpm\[[@B8],[@B9],[@B23]\]. The initial workload was determined by fitness level \[[@B9],[@B23]\]. Adequate rest was given between bouts to allow for participants\' heart rate to drop within 10 beats of their resting heart rate (averaging 10--15 minutes). The rate of rise in EMG amplitude values (EMG slope) from four fatiguing power outputs were plotted over 60 seconds (Figure [1a](#F1){ref-type="fig"}). The EMG slope values for each of the four power outputs were then plotted (Figure [1b](#F1){ref-type="fig"}) to determine EMG~FT~. The line of best fit was extrapolated to the y-axis and the power output at which it intersected was defined as the EMG~FT~. The participants completed the EMG~FT~protocol three times; familiarization (day 1), baseline (day 3) and post supplementation (day 9), respectively.

![a. The relationship between EMG amplitude and time for the four power outputs used in the EMG~FT~test for subject 5C. The greatest slope was a result from the highest power output. b. The relationship for the power outputs versus slope coefficients with the y-intercept defined as the EMG~FT~for subject 5C.](1550-2783-4-20-1){#F1}

Test-retest reliability for the EMG~FT~protocol was determined at the University of Oklahoma by using 10 healthy male and female participants measured 7--8 days apart. The intraclass correlation coefficient (ICC) was 0.935 (SEM 5.03 W), which was higher than previously reported for the vastus lateralis (ICC = 0.65) by Pavlet et al. (1993). In addition, there was no significant difference (p \> 0.05) between the mean EMG~FT~values from pre- (172.17 ± 14.12 W) to post- (165.95 ± 13.41 W).

Data Analysis
-------------

A two-way ANOVA (group \[Cr vs. PL\] × time \[pre vs. post\]) was used to identify any group by time interaction. When appropriate, follow up dependent t-test analyses were run on pre to post-EMG~FT~and body weight (BW) values. Furthermore, an independent samples t-test was used to recognize statistical significance among pre-supplementation variables (EMG~FT~and BW). All data are reported as mean ± S.E.

Results
=======

Table [2](#T2){ref-type="table"} shows the mean and standard error values for EMG~FT~and BW. A two-way ANOVA resulted in a significant interaction (*p = 0.024*) for group and time. There was a significant (*p = 0.031*) difference in absolute change from pre- to post-treatment in EMG~FT~between the Cr and the PL treatment groups (Fig [2](#F2){ref-type="fig"}). In addition, dependent-samples t-test indicated a 14.5% ± 3.5% increase in EMG~FT~from pre- to post-supplementation for the Cr treatment (*p = 0.009*), but no significant change for the PL treatment (*-*2.2 ± 5.8%; *p = 0.732*) (Table [2](#T2){ref-type="table"}). Cr supplementation resulted in a significant 1.0 kg ± 0.34 kg increase (*p = 0.049*) in BW (Fig [2b](#F2){ref-type="fig"}) from pre- to post-supplementation, but no change in the PL treatment group (-0.2 kg ± 0.2 kg).

![The effect of creatine supplementation on Electromyographic Fatigue Threshold (EMG~FT~; W) from pre- to post-treatment. Values are presented as mean ± SD. \*The post-supplemented mean EMG~FT~is significantly (p \< 0.01) higher than the pre-supplemented mean EMG~FT~.](1550-2783-4-20-2){#F2}

###### 

Mean and standard error (SE) values for electromyographic fatigue threshold and body weight for the pre- and post-supplementation trials with either the placebo or creatine.

                         Electromographic Fatigue Threshold (W)   Body Weight (kg)                
  ---------------------- ---------------------------------------- ------------------ ------------ --------------
  Pre-supplementation    152.3 ± 11.6                             121.9 ± 10.9       64.7 ± 2.9   66.0 ± 3.6
  Post-supplementation   149.5 ± 9.3                              142.6 ± 10.5\*     64.9 ± 2.9   66.8 ± 3.7\*

\*p \< 0.05 for pre- to post-difference

Additionally, independent samples t-tests demonstrated no significant differences between either pre-supplementation variables, p \> 0.05 for EMGFT and BW respectively.

Discussion
==========

Several studies have reported 4 to7 days of Cr loading is effective for enhancing anaerobic performance during repeated sprint cycling \[[@B24]-[@B27]\], resistance training \[[@B28],[@B29]\], and anaerobic treadmill running \[[@B30]\]. In addition, a few studies have demonstrated Cr loading to be an effective ergogenic aid for supramaximal workloads (\>120% VO~2\ max~) on a cycle ergometer \[[@B27],[@B31]-[@B33]\]. The increase in exercise performance is believed to be attributed to an increase in intramuscular stores of total PCr \[[@B15],[@B34]\]. A few investigators \[[@B11],[@B16],[@B33]\] have suggested that increasing skeletal muscle PCr from Cr loading may improve supramaximal cycle ergometry performance by decreasing the reliance on anaerobic glycolysis for energy. In theory, decreasing the contribution of anaerobic glycolysis to meet energy demands during supramaximal workloads may reduce intramuscular lactate and H^+^accumulation and, in turn, delay the onset of fatigue. In addition, Cr loading may also delay fatigue by increasing the rate of PCr resynthesis between intense exercise bouts, enhance buffering capacity, and provide greater shuttling of mitochondrial ATP into the cytoplasm \[[@B15],[@B18],[@B35]\].

McClaren et al. \[[@B5]\] suggested that a decrease in muscle pH, as a result of the accumulation of intramuscular H^+^or an increase in intracellular and extracellular ammonia, may be responsible for fatigue-induced increases in motor unit recruitment and the corresponding increase in EMG amplitude. In agreement, Taylor et al. \[[@B36]\] also found that, for incremental cycle ergometry, the accumulation of plasma lactate and ammonia was associated with an increase in EMG amplitude. Therefore, there is evidence to suggest that a significant reliance on anaerobic glycolysis leads to an increase in EMG amplitude from the working muscles, as a result of changes in muscle and blood lactate levels and the corresponding decrease in skeletal muscle pH \[[@B2],[@B36]\].

Moritani et al. \[[@B2]\] speculate that the EMG~FT~may be closely associated with a steady state of lactate metabolism and H+ accumulation in the active muscle. The level of exercise just below the point at which the bicarbonate buffering system can no longer maintain a homeostatic environment, due to an increase in H^+^, has been described as anaerobic threshold (AT) \[[@B37]\]. In support, deVries \[[@B14]\] and Matsumoto et al. \[[@B9]\] demonstrated a close relationship between AT and the EMG~FT~test. Furthermore, Matsumoto et al. \[[@B9]\] reported a significant relationship (r = 0.823; p \< 0.01) between AT and EMG~FT~with a similar subject sample of college-age women. In addition, Wasserman et al. \[[@B38]\] and Sirotic et al. \[[@B39]\] have demonstrated a strong relationship between AT and the ability of the cardiovascular system to supply oxygen during exercise, coupled with an improvement in performance. The results of our study indicated a 14.5% increase in EMG~FT~after 5 days of Cr loading, which are very similar to Nelson et al. \[[@B20]\] who reported a 15% increase in AT in men and women from 7 days of Cr loading using a graded exercise test (GXT) on a cycle ergometer. In addition, Stout et al. \[[@B11]\] using a similar cohort of college-age women, reported a 13% increase in neuromuscular fatigue threshold during a GXT. While our results were similar to Nelson et al. \[[@B20]\] and Stout et al. \[[@B11]\] at increasing estimated fatigue thresholds, the present study utilized a supramaximal discontinuous protocol, compared to a submaximal incremental test, to estimate anaerobic and neuromuscular fatigue thresholds. To our knowledge this is the first study to report the effect of Cr loading on the supramaximal EMG~FT~assessment, in women.

The EMG~FT~theoretically represents the highest power output that can be sustained, during cycle ergometry, for an extended period of time without signs of neuromuscular fatigue \[[@B9]\]. The primary findings of this study suggest that Cr loading may significantly increase the EMG~FT~in women, and thereby increase the power output that can be maintained on a cycle ergometer for an extended period of time without exhaustion. Additionally, in contrast to previous studies using women \[[@B34],[@B40],[@B41]\], the results of the present study for BW (Table [1](#T1){ref-type="table"}) showed a significant increase from pre- to post-Cr loading. Although there was a significant increase in BW, the change (\<0.8 kg) may have represented day-to-day fluctuations.

In conclusion, Cr loading in college-age women resulted in a significant increase in EMG~FT~(14.5%) when compared to the placebo group (-2.5%). The increase in EMG~FT~may have been due to the increased intramuscular PCr levels, attenuating the contribution of anaerobic glycolysis to ATP resynthesis \[[@B11],[@B16],[@B33],[@B42],[@B43]\]. Future studies that directly measure changes in skeletal muscle PCr and AT measures (EMG~FT~, lactate, ventilatory and ammonia thresholds) may be warranted to confirm these results.
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